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Class II molecules encoded by the MHC regulate the recognition offoreign an-
tigens on the surfaces ofAPC by T cells through a phenomenon known as MHC
restriction (1, 2). These molecules, also known as la antigens, play a major role in
the mixed lymphocyte response (3). In the mouse there are two class II isotypes,
I-A and I-E, whereas in man three majorclass II isotypes are expressed, DR, DQ,
and DP (reviewedinreference 4). Eachoftheclass II isotypesis aglycoprotein com-
posed ofan a and a ,B subunit. The high level ofallelic polymorphism in the mole-
culesis believed toreflect the variation required forthe generation ofspecific immu-
nity to infectious agents.
Sequences in the NH2 terminus, primarily in the 0 chain (5, 6), appear to regu-
latethe intracellular assembly oftheheterodimers, and generally, interisotypic pairing
is prevented in cells with a full complement ofa and fl chains. It has been shown
thata and 0chains ofa given haplotype can transassociate in certain heterozygotes
(7, 8). Recently, through the use of DNA-mediated gene transfer, the expression
ofmixed isotype dimers has been demonstrated in L cells transfected with certain
class II gene pairs (9, 10). In these studies, L cells transfected with Ad and Eak (9)
or Ed (10) genes produced f and a chains that paired successfully and were ex-
pressed at the cell surface. Furthermore, in this latter study, it was shown that al-
though several GATspecific Tcell hybrrdomms restricted to I-Ad failed to respond
to antigen presented by this transfectant, another T cell hybridoma, AODH-7.1,
specific for human gamma globulin (HGG)' in the context of I-Ed (11), was stimu-
latedbythe transfected Lcell in the presenceofantigen. Norcross et al. (12) reported
that the introduction of a mouse Ad ~ gene into a human lymphoblastoid cell line
resulted in the expression ofthe mouse Al3 chain at the cell surface as part ofamol-
ecule containing the endogenous DRa chain. Since the DR is homologous to I-E,
the pairing ofthe mouse A0 chain to the DR,,, chain was not anticipated. The most
direct evidence to date for the assembly and surface expression of mixed isotype
class II molecules in a nontransfected cell was presented by Lotteau et al. (13). A
mixed isotype molecule, DR,D0j, was shown to be expressed by a human EBV
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transformed cell line, PGF. This cell line also expressed the appropriate class II iso-
typic pairs, however, no DQc DRO molecule was detected.
In this study, we present evidence that the mouse B cell lymphoma, 2PK3, ex-
presses a mixed isotype molecule, Ed nAd, as a major class II molecule at the cell sur-
face. A normal I-E heterodimer is also expressed, but no I-A isotype is detected.
The mixed isotype molecule is capable of presenting antigens restricted by I-Ad,
although the responses induced are consistently weaker than responses generated
by the normal I-Ad isotype. Furthermore, antigen presentation by the mixed iso-
type molecule is inhibited by mAb reagents specific for I-A and I-E, respectively.
The 2PK3 lymphoma cells induce a strong proliferative response by syngeneic T
cells, which is inhibitable by an anti-I-Ad mAb.
Materials and Methods
Animals.
￿
BALB/c and CBA/J mice were bred at the National Jewish Center for Immu-
nology and Respiratory Medicine (Denver, CO) and were 8-10 wk of age when used. Arme-
nian hamsters were obtained from Cambridge Diagnostic Laboratory (Cambridge, MA).
Cell Lines.
￿
The B cell lymphoma line A20-1.11 (A20) (14) was originally obtained from
Drs. K. J. Kim and R. Asofsky (National Institutes of Health, Bethesda, MD), and 2PK3
was obtained from American Type Culture Collection (Rockville, MD). Both lymphomas
are of BALB/c origin, express la antigens, and have been shown to function as APC (15).
B cell lymphoma variants expressing only I-Ad (M12 .B5) or I-Ed (M12.A2) were originally
obtained from Dr. L. Glimcher (Harvard School of Public Health, Boston, MA) (16). Allo-
reactive T cell hybridomas AC5, CG4, DG11, EE10.D8, and JB9 recognizing either I-Ad or
I-Ed have been characterized previously (17). T cell hybridomas recognizing chicken OVA in
context of I-Ad (DO-11.10, 3130-18.3, 3130-20.10, 3130-54.8, and 4130-44.1) have been de-
scribed (18) and were kindly provided by Drs. J. Kappler and P Marrack (National Jewish
Center for Immunology and Respiratory Medicine) . The T cell hybridomas ME1, recogniz-
ing X repressor peptide 12-26 (X-rep [12-26]) in context of I-Ed, and LFE-1, recognizing
sperm whale myoglobin peptide 132-153 (Myo[132-153]) in context of I-Ed, were provided
by Dr. M. Gefter (Massachusetts Institute ofTechnology, Cambridge, MA). The T cell line
AODH-7 .1 recognizes HGG in context of I-Ed (I1). A20 and 2PK3 were grown in RPMI
1640 supplemented with 10% FCS (HyClone Laboratories, Logan, UT) and 5 x 10-5 M
2-ME (Eastman Kodak, Rochester, NY). All other cell lineswere maintainedin MEM (formula
78-5067 ; Gibco Laboratories, Grand Island, NY) plus a nutrient cocktail as described (19).
Antibodies.
￿
mAbs MK-136 (reactive to Ad o [19]) and 14-4-4S (reactive to E420]) were pro-
duced as ascites in pristane-primed, sublethally irradiated (600 rad) BALB/c mice. Antibodies
were purified via passage over protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway,
NJ) columns. K24.199, specific for Aa (21, 22), was used as culture supernatant. Polyclonal
antibodies to the individual subunits of the la antigens were produced in hamsters by in-
jecting electroeluted a or 6 chains from specifically purified I-A or I-E isolated from A20
or 2PK3. Ia antigens were subjected to electrophoresis on SDS-PAGE and gel slices con-
taining a or (3 chains were electroeluted using an electroelution apparatus (C. B. S. Scientific
Co., San Diego, CA) as described previously (23). Hamsters received 5-10 pg antigen per
injection subcutaneously, the first injection in CFA and subsequent injections in IFA.
Flow Cytometric Analysis.
￿
The mAbs were protein A purified and used at a concentration
of 10 Ftg/ml. Approximately 106 B cells were incubated with -0.5 hg primary mAb. After
washing, FITC protein A (Sigma Chemical Co., St. Louis, MO) was used as the developing
reagent. Cells were routinely fixed in PBS/1 To formaldehyde before cytofluorometic analysis
on an Epics C flow cytometer (Coulter Electronics Inc., Hialeah, FL).
Affinity Purification ofla Antigens.
￿
This procedure was carried out as described (17). Several
passages and elutions were performed to remove all ofthe I-A, followed by specific purification
of I-E in the same manner.
Chemical Deglycosylation ofla Antigens.
￿
The complete removal of carbohydrate was accom-
plished using acid hydrolysis of glycosidic linkages following the procedure of Edge et al.SPENCER AND KUBO
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(24). Briefly, -20 hg protein was precipitated with acetonitrile, dried under a stream of N2,
suspended in 45 pl of anhydrous trifluoromethanesulfonic acid and 5 pl anisole, and incubated
on ice for 2 h. The mixture was then added to 1 ml of pyridine/ethyl ether (1 :9) in a dry
ice/acetone bath. After centrifugation at 10,000 g for 10 min, the pellet was dissolved in 0.1 M
NH4HCO3 and dialyzed against PBS.
Cell Surface Labeling with .151for Immunoprecipitation.
￿
Cells were surface labeled with Na'25I
(ICN Biomedicals, Costa Mesa, CA) using Iodogen (Pierce Chemical Co., Rockford, IL),
followed by solubilization of membrane proteins with 1 % NP-40 lysing buffer (19). For im-
munoprecipitation, 10 ftl of wholeantiserum or protein A-purified mAb (1 mg/ml) were added
to 2-4 x 106 cpm of detergent lysate and the mixture was incubated overnight at VC. Pro-
tein A-Sepharose (Sigma Chemical Co.) (200 pl ofa 50% suspension in PBS) was added and
mixed at room temperature for 2 h, followed by washing five times with 0.5% NP-40 in PBS.
Complexes were eluted by boiling in Laemmli sample buffer containing either iodoacetamide
or 2-ME at concentrations of0.5 M and 57o for unreduced and reduced conditions, respec-
tively. Immunoprecipitates were analyzed by SDS-PAGE using 10% polyacrylamide minigels.
Driedgels were autoradiographed using Kodak XAR5 film and intensifying screens at -70'C.
Solid Phase RIA.
￿
Approximately 4 ILg of specifically purified Ia antigen in 50 Al was al-
lowed to bind to wells of flexible polyvinyl chloride round-bottomed microtiter plates (Dy-
natech Laboratories, Inc., Alexandria, VA) for 1 h at room temperature followed by a wash
with PBS and blocking of unbound sites with 5% nonfat dry milk in PBS (M/PBS) with
0.02% sodium azide. Antibody reagents (appropriate dilutions ofculture supernatant or protein
A-purified antibody from ascites) were added in 50-Al amounts and incubated 1 h followed
by washing with PBS. The binding of mAbs was detected by the addition of 1211-labeled pro-
tein A (25,000 cpm), followed by cutting ofthe wellsfrom the plates, and counting in a gamma
counter.
Immunoblotting
￿
The reactivityofhamster polyclonal sera to I-A and I-E antigens was ana-
lyzed by immunoblotting. Approximately 1 gg of specifically purified I-A or I-E was sub-
jected to electrophoresis under nonreducing conditions on a 10% SDS-PAGE gel. After this,
the proteins were electrophoretically transferred from the gel to nitrocellulose (NC) at 150 mA
for 1 h in a Polyblot apparatus (American Bionetics, Hayward, CA). After the transfer was
completed, nonspecific sites on the NC were blocked with M/PBS for 15 min, followed by
incubation with the appropriate dilution ofantibody (usually 10 pl serum to 10 ml ofM/PBS),
and incubated overnight on a mechanical shaker at 4°C. The NC was washed extensively
with PBS and then incubated with 106 cpm'25I-labeled protein A for 2 h at 25°C, washed,
dried, and placed on film for autoradiography.
Tryptic Peptide Mapping ofA20 and 2PK3 Ia a and 0 Chains.
￿
Specifically purified A20 and
2PK3 I-A and I-E molecules were subjected to electrophoresis on 10% polyacrylamide gels
under nonreduced conditions to separate the a and 0 chains. The gels were fixed and stained
with Coomassie blue. Gel segments corresponding to the a and asubunits were excised and
the proteins were recovered and processed for trypsin digestion as previously described (23).
The digested proteins were injected onto a 4.6-mm x 30-cm Cis 300 A reversed phase
column installed on an HPLC system (model 721; Waters Associates, Milford, MA). The
peptides were eluted with a flow rate of 1 ml/min with a linear gradient of0.1 % TFA in acetoni-
trile to 50% over 90 min. The elution was monitored at 214 nm and fractions were collected
at 30-s intervals. The sequencingof selected peptides was performed on a protein sequencer
(model 470A; Applied Biosystems, Inc., Foster City, CA) using a modified Edman chemistry.
Stimulation ofIL-2 Production by T cell Hybridomas.
￿
For alloreactive T cell hybridoma re-
sponses, microculture wells were prepared containing 200 p.l of culture medium, 2 x 105
hybridoma cells, and 105 B lymphoma cells. For antigen presentation, microculture wells
were prepared containing 300 p,l of culture medium, 105 hybridoma cells, 105 B lymphoma
cells as APC, and 100 hg of appropriate antigen. A Tptic digest of chicken OVA (Sigma
Chemical Co.) was used in most antigen stimulation assays requiring OVA. HGG was purified
from Cohn fraction II by DEAE cellulose chromatography. Peptides OVA(323-339), A-rep(12-
26), and Myo(132-153) were synthesized as described (25) and were added at 10 pg per cul-
ture. The cultures were incubated at 37°C in flat-bottomed, 96-well microtiter plates. Super-
natants from these cultures were harvested 24 h later and then were assayed for the presence
of IL-2 (19).628
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Stimulation ofAutologous TCellsbyA20and2PK3 in aPrimaryMLR.
￿
T cells were obtained
from the spleens of nonimmune BALB/c or CBA/J mice. Accessory cells were depleted by
passing the spleen cells over nylon wool and 0-10 columns as described (26). The T cells
(4 x 105 cells per well) were cultured with various numbers of mitomycin C-treated B cells
in a final volume of 0.3 ml of complete medium in flat-bottomed, Linbro 96-well microtiter
plates (Flow Laboratories, Inc., McLean, VA). The cultures were incubated at 37°C for a
total of 5 d. Approximately 8 h before harvesting the cultures, 1 gCi of [3H]thymidine (6.7
Ci/mM; New England Nuclear, Boston, MA) was added to each well. The wells were har-
vested by using a Titertek cell harvester (Flow Laboratories, Inc.), and [3H]thymidine in-
corporation was determined by using a liquid scintillation spectrometer.
Results
Comparison ofthe Antigen-presenting Capabilities of2PK3 andA20.
￿
Previous studies
have shown that the A20 cell line functions well as an APC to antigen-specific MHC-
restricted T cells (15) and as a stimulator cell for alloreactive T cells (17). When the
functional capacity of 2PK3 cells to serve as APC was analyzed in comparison with
that of A20, differences were noted (Tables I and II). Most notably, I-Ad-specific
alloreactive T cell hybridomas reacted poorly to 2PK3 but responded well to A20.
However, 2PK3 stimulated I-Ed-specific T cell hybridomas well, and in some cases,
more effectively than did A20 (e.g., EEl0.D8). Differences in the ability to present
antigen to antigen-specific, MHC-restricted T cell hybridomas were also observed
particularly in the case of I-Ad-restricted responses. As shown in Table 1, OVA-
specific responses restricted by I-Ad were stimulated when A20 was used as the
APC, whereas responses to antigen presented by 2PK3 to the same T cell hybrid-
omas were much lower or undetectable. Three I-Ed-restricted, antigen-specific T
cell hybridomas examined, specific for HGG, A-rep(12-26) peptide, and Myo(132-153)
peptide, did respond well to antigen presented by either 2PK3 or A20. These results
TABLE I
Stimulation of Alloreactioe andAntigen-specific T Cell Hybridoms
by A20 and 2PK3
2 x 105 alloreactive or 105 antigen-specific T hybridoma cells were incubated
for 24 h with 105 A20 or 2PK3 B lymphoma cells. For antigen presentation,
antigen was added to the cultures as described below. Supernatants were then
harvested and assayed for IL-2 content.
$ A titer of <20 indicates undetectable quantities of IL-2 .
S Tryptic digest of OVA, 1 mg/ml; 100 Wl added.
II Whole HGG, Cohn fraction II, 1 mg/ml; 100 wl added.
Hybridoma' Specificity
IL-2 titer
Stimulator cell
A20 2PK3
U/mt
AC5 I-Ad >1,280 <201
DG11 I-Ad 640 80
JB9 I-Ad 320 <20
EE10.D8 I-Ed 40 1,280
CG4 I-Ed 640 1,280
3DO-18.3 OVAS/I-Ad 160 <20
3DO-20.10 OVA/I-Ad 320 <20
4DO-44.1 OVA/I-Ad 320 20
AODH-7.1 HGGII/I-Ed 320 640SPENCER AND KUBO
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TABLE 11
Inhibition of Antigen Presentation with mAb Specific for I-A or I-E
' Protein A-purified MK-D6 (AS specific) or 14-4-4S (Eo specific); 50 Al at 1
mg/ml added to cultures.
$ Tryptic digest of OVA; 50 pl, 2 mg/ml added.
§ Irrelevant mAb added.
B Sperm whale myoglobin (132-153) peptide; 50 Al, 0.2 mg/ml added.
X repressor (12-26) peptide; 50 ul, 0.2 mg/ml added.
indicate that A20 and 2PK3 differed in their ability to perform MHC-restricted
functions.
The differences in Ia-stimulatory capacity between A20 and 2PK3 could be due
to variations in la antigendensity or to structural differences in theIa antigens them-
selves. We had previousy quantified the I-Ad and I-Ed expression by an RIA using
radiolabeled MK-D6 and 14-4-4S mAbs, respectively, and found that A20 cells on
an average expressed _106 I-A molecules per cell and _4-5 x 105 molecules of I-E
per cell, whereas 2PK3 cells expressed only 50% of the amount of "I-A" but twice
the number of I-E molecules per cell as did the A20 cells (S. Fobare and R. Kubo,
unpublished results). These differences in la antigen densities alone were probably
not sufficient to account for the poor I-A-presenting capacity of 2PK3.
The effect of the addition of MK-D6 or 14-4-4S on the presentation of OVA by
A20 and2PK3 to theTcell hybridomas DO-11.10 and 3DO-54.8 wasanalyzed (Table
II). As expected, the addition of MK-D6 inhibited the presentation of OVA by both
A20 and 2PK3, and the addition of 14-4-4S had no effect on the ability of A20 to
present OVAto the two Tcell hybridomas. In addition, presentation of X-rep(12-26)
and Myo(132-153) to I-Ed-restricted T cell hybridomas LFE-1 and ME1, respec-
tively, wasmarkedly inhibitedby 14-4-4S andnot MK-D6. Takentogether, the results
indicate that MK-D6 and 14-4-4S were specific in their ability to inhibit antigen
presentation by A20. Unexpected results were observed with 2PK3; the stimulation
of both DO-11.10 and 3DO-54.8 was completely inhibited or markedly reduced by
the addition of either MK-D6 or 14-4-4S. This inhibition by MK-D6 and 14-4-4S
provides strong evidence that theclass II restriction elementon 2PK3 involved with
presenting OVA to the T cell hybridomas was not a conventional I-Ad molecule.
Hybridoma Antigen mAb'
IL-2 titer when
A20
Exp. 1 Exp. 2
stimulated
Exp. 1
by:
2PK3
Exp. 2
DO-11 .10 OVAt/I-Ad -S 640 640 80 40
OVAA-Ad MK-D6 <20 20 <20 <20
OVA/I-Ad 14-4-4S 640 640 <20 <20
3DO-54.8 OVA/I-Ad ' - 80 160 80 80
OVA/I-Ad MK-D6 <20 20 <20 <20
OVA/I-Ad 14-4-4S 80 160 <20 20
MEl SWMI/I-Ed - 640 320
SWM/1-Ed MK-D6 640 320
SWM/1-Ed 14-4-4S 40 40
LFE-1 X-repl/1-Ed - 320 320
a-rep/I-Ed MK-D6 160 160
X-rep/I-Ed 14-4-4S 20 20630
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It has been previously reported that DO-11.10 and 3130-54.8 can recognize
OVA(323-339) in the context of I-Ad (18) and it has also been shown that this pep-
tide can bind to I-Ad but not to I-Ed (27). Furthermore, we have shown that a
variant B cell lymphoma M12.A2, which expresses I-Ed but not I-Ad (16), was not
able to present OVA(323-339) to either DO-11.10 or 3130-54.8, whereas the variant
MUM, which expresses I-Ad but not I-Ed (L. Glimcher, personal communication),
presented the OVA peptide effectively (data not shown). It would appear that 2PK3
uses the unusual class II molecule to present the OVA(323-339) peptide and that
this molecule bears epitopes recognized by both MK-136 and 14-4-4S. A mixed iso-
type structure with the composition of Ed QAp would have this feature. The structural
analysis of this molecule presented below supports this notion.
Both A20 and 2PK3 induced strong allogeneic responses using CBA/J splenic
T cells as responders (Table III). Quite interestingly, 2PK3 induced a strong syn-
geneic response with BALB/c splenic T cells, whereas the A20 cells appear only mar-
ginally effective as syngeneic stimulators. Both allogeneic and syngeneic stimula-
tory responses mediated by 2PK3 were inhibited by the addition of MK-136 to the
cultures, suggesting that class II molecules were primarily responsible forthe stimu-
lations observed.
StructuralAnalysis ofIa Antigensfrom A20 and 2PK3.
￿
The structure of the I-A and
I-E molecules of A20 and 2PK3 was initially characterized using the cell surface
labeling technique. Each of the cell lines was surface labeled with Na1251, lysed with
detergent, and the clarified lysate subjectedto immunoprecipitation with either MK-
D6 or 14-4-4S mAbs. SDS-PAGE analysis oftheimmumoprecipitates in an unreduced
state (which allows for better resolution of the subunits) revealed that both the a
and/3 chains ofA20 I-A were radiolabeled, while preferential labeling of the /3 chain
of the 2PK3 I-A was observed (Fig. 1). In the case of the I-E molecules, the A20
and 2PK3 patterns were essentially identical to the 2PK3 I-A pattern in that only
the /3 chains were labeled (Fig. 1). These results again suggested that the I-A mole-
cules of A20 and 2PK3 were different. The lack of incorporation of radiolabel into
TABLE III
Comparison of A20 and 2PK3 to Act as Stimulator Cells in a One-way MLR
' Splenic T cells and stimulator B cells were prepared as described in Materials and Methods.
1 mAb was added in the form of 100 Al culture supernatant .
S 4 x 105 T cells were added to the indicated number of mitomycin C-treated B cells in 0.3 ml and were incu-
bated for 5 d. They were pulsed with 1 uCi [3H]thymidine for the last 8 h ofculture. Values represent the
mean oftriplicate cultures t SD. Thymidine incorporation in the absence of stimulator cells was <600 cpm.
Responder
T cells'
Stimulator
B cells` mAbl 2 x
Incorporation of [3H]thymidines
Stimulator cells per culture
105 2 x 104 2 x 103
cpm
BALB/c A20 - 2,014 t 214 1,546 t 632 1,132 f 397
BALB/c 2PK3 - 37,249 t 6,400 10,074 t 2,497 2,274 t 475
CBA/J A20 - 154,067 ± 26,495 16,287 t 3,730 420 f 58
CBA/J 2PK3 - 122,880 t 15,383 124,769 ± 26,732 58,761 t 12,302
BALB/c 2PK3 MK-136 5,201 t 1,551 5,649 t 568 3,179 ± 463
CBA/J 2PK3 MK-136 8,256 t 1,026 18,662 t 2,957 3,732 f 689SPENCER AND KUBO
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FIGURE 1 .
￿
SDS-PAGE analysis ofradiolabeled I-A
and I-E antigens from A20and 2PK3 cells . Cells were
subjected to surface radioiodination, detergent lysis,
and subsequent immunoprecipitation with mAbs
specific for I-A(MK-D6) (lanes 1and 2)andI-E (14-
4-45) (lanes3and 4) . Immunoprecipitates from A20
are in lanes I and 3, and those from 2PK3 are in
lanes 2 and 4 . Samples were analyzed under non-
reducing conditions . Numbersat the left margin in-
dicate the positions ofprotein molecular weight stan-
dards: 69, BSA; 45, OVA; 29, carbonic anhydrase,
with apparent molecular weights of 69,000, 45,000,
and 29,000, respectively.
the Ea chain and thea chain of the 2PK3 I-A molecule limited the use ofthis tech-
nique for further structural studies.
The la antigens were preparatively purified by affinity chromatography usingMK-
D6- and 14-4-4S-conjugated Sepharose beads as describedin Materials andMethods.
Approximately5 ug of each la antigen preparation was analyzed bySDS-PAGE under
nonreducing conditions and the protein bands were revealed by staining with
Coomassie Brilliant Blue (Fig. 2) . Resolution ofthea and 0 subunits is readily ob-
tained for both I-A and I-E . After reduction, the I-Ea and 0 subunits have similar
mobilities and are poorly resolved (data not shown), whereas thea and0 subunits
of the I-A antigen are still well separated under these conditions . The I-E molecules
from the twoB celllymphomas have similar patterns . Attempts at enzymatic degly-
cosylation (N-glycanase or endoglycosidase F) resulted in only partial removal of
carbohydrate on some chains . For this reason, we chose to use chemical deglycosyla-
tion, which completely removed carbohydrate from all subunits . The slight differ-
ences seen in the I-E patterns could be eliminated by chemical deglycosylation of
theseproteins, suggesting that variations in carbohydrate moieties accounted for the
differences in subunitmobilities . Thepatterns of the I-A molecules also show differ-
ences in the subunits . After chemical deglycosylation, the 2PK3 "I-A" a chain
comigrated with the I-E a chain and not with the A20 Aa chain . The A(3 chains
of A20 I-A and 2PK3 "I-A" comigrated after deglycosylation (data not shown) .
To determine whether thea chain associated with the molecule that we had pre-
sumed to be 2PK3 "I-A" by virtue of the reactivity with MK-D6 was identical to
or related to Ec , chain ofA20 I-E, the a anda chains of the I-A and I-E molecules
from A20 and the "I-A" from 2PK3 were isolated by preparative SDS-PAGE and
FIGURE 2 .
￿
SDS-PAGE analysis ofunreduced I-AandI-E
specifically purified from A20 and 2PK3 on MK-D6 and
14-4-45 Sepharose affinity columns . Approximately 5 lAg
of affinity-purified I-A from A20 (lane 1) and 2PK3 (lane
2), and affinity-purified I-E from A20 (lane 3) and 2PK3
(lane 4) were subjected to electrophoresis and subsequently
visualized by Coomassie Brilliant Blue staining. Positions
of molecular weight standards are indicated on the left
margin as in Fig . 1 .632
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subsequent electroelution of the protein from excised gel segments as described in
Materials and Methods. Each ofthe subunits was digested with trypsin and the digests
were subjected to peptide mappingby HPLC chromatography. The elution profiles
of the digests of the 2PK3 "I-A" a chain and A20 E« chains were almost identical
with the exception of minor variations in the regions of several peaks, which may
be due to differences in glycosylation (Fig. 3 A). Each of these patterns, however,
is distinct from that of the A20 A« chain. The patterns of the A/3 chains were essen-
tially identical.
The peptides in the peaks labeled a, b, and c in Fig. 3 A were each subjected to
amino acid sequence analysis to help confirm the identification ofthe 2PK3 a subunit.
Fig. 3 Bshowsthe four peptide sequences obtained. Peaksb andc each yielded single
unambiguous sequence that could be aligned with the known sequence reported
for E« (28). The sequence of peptide 3 terminated with the identification of the
serine residue. In the predicted sequence this is followed by an arginine residue,
however, this residue could not be reliably identified in our analysis of peptide 3.
Sequence analysis of the material in peak a indicated the presence of two peptides
in significant molar ratios. A comparison of the amino acid residues obtained at
each cycle with the predicted amino acid sequence of the Ed chain was used to de-
termine these two sequences. Neither of these sequences occur in the Ad chain. The
results of these structural data lead us to conclude that the a chain associated with
the Aa chain in 2PK3 is E«, indicating that a mixed isotype class II molecule, EdAa,
is the major (if not exclusive) MK-D6-reactive molecule expressed by 2PK3 .
AntigenicAnalysis oftheIa Antigens.
￿
Studies on the antigenic analysis of the la an-
tigens of A20 and 2PK3 further supported the notion that the 2PK3 cell line ex-
pressed a mixed isotype class II molecule. The affinity-purified I-A and I-E mole-
cules were analyzed using a solid phase RIA that used MK-D6 and 14-4-4S mAbs
(Table IV). The A20 I-A reacted only with MK-D6 and the I-E molecules of A20
and 2PK3 (both of which had been purified using 14-4-4S after the cell lysates were
depleted of I-A on MK-D6-Sepharose) reacted only with 14-4-4S. The 2PK3 "I-A"
molecule reacted with both MK-D6 and 14-4-4S.
TheI-A and I-E molecules from A20 and 2PK3 were further analyzed by immu-
noblot usingchain-specific hamster antisera prepared againstthe individual subunits.
Hamsters were individually immunized with electroeluted Act chains from A20 I-A,
A/3 chains from A20 I-A, Ea chains from 2PK3 I-E, or E(3 chains from A20 and
2PK3 I-E. The specificity of the antisera probes was determined by immunoblot
againstI-A and I-E antigens from A20 and2PK3 (Fig. 4A). The anti-Au antiserum
detected the a chain of A20 I-A but did not react with the a chain of I-E or 2PK3
"I-A". Anti-Ea detected the a chain of A20 and 2PK3 I-E but not the a chain of
A20 I-A. Anti-E/3 detected the /3 chain of A20 and 2PK3 I-E. Antiserum against
A(3 reacted strongly with A/3(Fig. 4A, lanes 7and 8) but also showed aweak cross-
reactivity to E(3(datanot shown). Using these antisera, analysis of 2PK3 "I-A" yielded
the anticipitated result: the a chain was recognized by Eca-specific (Fig. 4 A, lane
4), but not Act-specific antiserum (Fig. 4 A, lane 1), while the /3 chain was recog-
nized by only the AO- (Fig. 4 A, lane 8), and not E(3- (Fig. 4 A, lane 10), specific
antiserum. This analysis confirmed that the 2PK3 "I-A" is composed of an Eat and
an A(3. In addition, the apparent differences in mobilities seen between the Ea chainsSPENCER AND KUBO
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FIGURE 3.
￿
Evidence forthe 2PK3 I-A
achain being an Ea chain. (A)Tryptic
digests of 2PK3 Aa," A20 Ea, A20
Aa, A20 A#, and 2PK3 AS chains in-
dividually isolated from preparative
SDS-PAGE were fractionated on a4.6-
mm x 30-cm Cis 300Apore reversed
phasecolumn by HPLC, with the re-
sultingelutionprofiles shown foreach
subunit as indicated. Thex-axis repre-
sents time while they-axis represents
theOD measured at 214rim. (B)Peaks
a, b, and c from 2PK3 Ao" and A20
Ea were subjected to amino acid se-
quence analysis. Peaks b and c each
yieldedsingle unambiguous sequences
that couldbe aligned with the known
sequence reported for Ea. The se-
quence of peptide 3 terminated with
the identification of theserine residue.
Although this should be followed by an
arginine residue, we could not reliably
identifythis in ouranalysis. Peak acon-
tained twopeptides in significant molar
ratios and, therefore, thetwosequences
had to be resolved by comparing the
amino acid residues obtained at each
cycle with thepredictedaminoacid se-
quence of the Ed chain.
of the mixed isotype and I-E molecules as well as mobility differences between the
A(3 chains ofthe mixed isotype and A20 I-Amoleculeswere eliminated afterdeglyco-
sylation of the chains (Fig. 4 B).
The mAb K24.199 (21) has been recently reported to be specific for A« (22). Thus,
the reactivity ofthis mAb to either A20or 2PK3 was compared with that of MK-D6
and 14-4-4S by immunofluorescent staining analysis. Both A20 and 2PK3 stained
brightly with both MK-D6 (Ad specific) and 14-4-4S (Ea specific) (Fig. 5). A20
reacted well with K24.199, however, no staining of 2PK3 with this mAb was de-
tected. Thus, by this analysis as well, no expression of Aq on the surface of 2PK3
cells could be demonstrated.
B
E
d
Peak Peptide Sequence Position in Domain
a 1 DDHLFRK 145-151 a2
a 2 TL.LPETK 188-194 TM
b 3 SNNTPDANVAPEVTVLS 81-97
c 4 NGRPVTTGVSETVFLPR 128-144 a2634
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TABLE IV
Solid Phase RIA Identifying Determinants Found on Affnity-purified
A20 and 2PK3 I-A and I-E
' Approximately 4 Wg ofeach antigen was coated onto wells ofmicrotiter plates .
1 Binding ofmAb detected with 1211-labeled proteinA . Values (cpm) represent
the mean ofduplicate wells . Binding ofan irrelevantmAb gave a background
of <500 cpm .
FIGURE 4.
￿
Immunoblot analysis of I-A and I-E specifically purified by MK-D6 and 14-4-4S
from A20 and 2PK3 (A). 2PK3 "I-A7 (lane 1), A20 I-A (lane 2), and 2PK3 I-E (lane 3) were
probed with an Act-specific hamster antiserum. 2PK3 "I-A7 (lane 4), A20 I-A (lane 5), and A20
I-E (lane 6) were probed with an Ect-specific antiserum . In lanes 7 and 8, A20 I-A and 2PK3
"I-A, respectively, were probed with an Af-specific antiserum. A20 I-E(lane 9), 2PK3 "I-A7 (lane
10), and 2PK3 I-E (lane 11) were probed with an EO-specific antiserum. (B) The differences
observed in the mobilities of the A20 I-E (lane 1), 2PK3 "I-A7 (lane 2), and 2PK3 I-E (lane 3)
Ect chains were eliminated after chemical deglycosylation . Similarly, mobility differences in the
A/3 chains of A20 I-A (lane 4) and 2PK3 "I-A7 (lane 5) were also eliminated .
Coat antigen'
mAb used
MK-D6 14-4-4S
cpm
A20 I-A 13,5001 420
A20 I-E 450 13,370
2PK3 I-A 13,050 11,960
2PK3 I-E 750 11,090SPENCER AND KUBO
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FIGURE 5 .
￿
2PK3 does not expressAa
on its surface. Flow cytometric histo-
grams are shown for A20 and 2PK3
stained with K24.199 (Ad specific),
MK-D6 (Adg specific), and 14-4-4S
(Ea specific) . The secondary reagent
was FITC protein A. 2PK3 did not
show any staining over background
with the Act-specific reagent .
Discussion
For the expression of functional Ia molecules on the cell surface, proper pairing
ofa and /3 class II gene products is required (29) . The bulk of data on the protein
chemistry of class II molecules has indicated that these molecules exist as intraiso-
typic pairs . Thus, in the mouse, Aa and A# chains associate to form the isotypic
heterodimer, I-A, and Ea combines with ES to form the second isotypic pair, I-E .
While it is generally held that only intraisotypic pairing is possible, there have been
a few reports that have suggestedthat mixed isotypeclass II molecules exist . In the
analysis of immunoprecipitates formed with the anti-I-E mAb, Y-17, which recog-
nizes a conformational epitope expressed by certain E«Eo complexes, Lerner et al .
(30) observed radiolabeled products that had the characteristics ofAa chains . This
observation could be explained by the immunoprecipitation of an AUEO molecule
with Y17, however, no formal proofof such amoleculewasoffered . In another situa-
tion, the cells of theATFR5 mouse show the surface expression ofEa determinants,
although there is no synthesis ofES chains (31) . The possibility exists that the low
amounts of Ea detected were due to the expression of a molecule composed ofEa
and A# chains . Finally, Maloy et al . (32) reported the possible existence of mixed
isotype class II molecules in spleen cells of H-2d haplotype mice through the use
of sequential immunoprecipitation in combination with radiochemical amino acid
sequencing .
The results of this study provide what we believe is the first report of the expres-
sion of a mixed isotype class II molecule at high density on a murine B cell lym-
phoma . Malissen et al . (10) presented data that indicated thatamixedisotype mole-
culewas apparently expressed at alow but significant level on theB cell lymphoma,
A20.2JAGR, although no biochemical characterization of the molecule was pre-
sented . Studies have shown that polymorphic residues in the NH2 terminus of the
0 chain regulate the efficiency of expression of Ia antigens (5, 6) . Undernormal cir-636
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cumstances in B cells with afull complement ofa and/3 subunits, assembly of intra-
isotypic pairs would be favored. Certain conditions may predispose a cell to the ex-
pression of isotypically mismatched a anda pairs. Imbalanced class II antigen ex-
pression has been observed in murine B cell lymphomas(33). It may also be possible
that in the up-regulation of class II expression resulting from lymphokine stimula-
tion, nonstoichiometric production of the different class II subunits may allow for
significant levels of mixed isotype pairing.
In addition to the mixed isotype molecule, the 2PK3 cellsexpress normal isotypic
I-E molecules. It is unlikely that 2PK3 expresses any normal I-A since we were not
able to detect surface expression ofAceby immunofluorescence usingthemAbK24.199,
and an immunoblot analysis of the MK-D6-purified molecule from 2PK3 usingpoly-
clonal hamster antisera specific for theAu chain was also negative. Preliminary ex-
periments have indicated that the level of Aa mRNA in 2PK3 is comparable with
the level expressed in A20 (J. Spencer, unpublished observations). Whether or not
the Aa mRNA is functional in 2PK3 is currently being investigated. The lack of
expression could be accounted for by amutation(s) in either theAa or A# gene that
interferes with normal isotypic chain pairing or perhaps to some other as yet to be
elucidated factors. We have noted some differences in the migration pattern of the
2PK3 A0 chain in comparison with that of A20 Ap by one- and two-dimensional
gel analysis. Thesedifferences appear to be primarilydueto differences in glycosyla-
tion. It has been previously described that the assembly and expression of class II
molecules arenotdependenton glycosylation, nevertheless, it could be possible that
unusual changes in carbohydrate processing in a tumor cell line could influence as-
sembly and/or transportof some multimeric proteins. The2PK3 Ea chains associated
with theA/3 and E/3 also show differences in migrationthat are eliminated on degly-
cosylation. This findingis interesting because it suggests that Ea is glycosylated differ-
ently depending on which a chain it is associated with.
Since 2PK3 expresses no normal I-A, then the presentation of OVA(323-339) to
the OVA-specific, I-Ad-restricted T cell hybridomas, DO-11.10 and 3DO-54.8, must
be mediated by the mixed isotype class II molecule. The ability of both MK-D6
and 14-4-4S to completely inhibit the responses of the two T cell hybridomas to
OVA(323-339) presented by 2PK3 supports this notion. Furthermore, aB cell lym-
phoma variant that expressed only I-Ed, M12.A2 (16), does not present the OVA
peptide to the T cell hybridomas. The responses ofthe T cell hybridomas to different
doses of antigen presented by 2PK3 are generally lower than responses mediated
by A20 cells, however, the difference in the density of MK-D6 reactive epitopes on
2PK3 as compared with A20 (50%) does not appear to adequately account for the
lowered responses to 2PK3. It would be expected, however, that the OVA peptide
may display alower binding affinity to themixedisotype molecule as compared with
the normal I-Ad molecule. This would account for the lower efficiency in the pre-
sentation of the OVA peptide by 2PK3 . In a preliminary study the binding of
OVA(323-339) to an affinity-purified mixedisotypemolecule was measured and the
resultsindicatedundetectable levels ofbinding(S. Buus andJ. Spencer, preliminary
observations). We assume that the level of sensitivity of the peptide binding assay
is considerably less than that seen with the stimulation assay. Thus, the peptide binding
assaymight yield negative results, although low levels of IL-2 aredetected in a stim-
ulation assay.SPENCER AND KUBO
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The ability of the EdgAd molecule to present the OVA peptide is intriguing. The
recent description of the three-dimensional structure of a human class I molecule
indicates that the a1 anda2 polymorphicdomains interact tightlyto form a unique
quarternary structurewithin which antigenic peptides couldbind andbe recognized
by appropriate T cells (34). It has been suggested that a similar binding site could
be formed by the cd and 01 domains of Ia antigens (34). The same T cell hybrid-
omas recognize OVA(323-339) in the context of normal I-A or EW mixed isotype
molecule. Thus, the Ad chain may play a dominant role for both peptide interac-
tion and MHC restriction in this particular situation, while the Ad chain may only
play a role in stabilizing the binding site, a role that could be subserved by the Ed
chain in the case of the mixed isotype molecule. In the latter situation, however,
the peptide binding site may be slightly altered such that a lowering in the affinity
of peptide forthe bindingsite is seen. Nevertheless, significant bindingandrestricted
antigen presentation results. Further investigations with known peptides restricted
by either I-Ad or I-Ed are needed to extend the observations.
Combinatorial associations would appear to benefit the individual by expanding
the I region immune response capabilities, although in certain instances, unusual
pair formations or the expression of modified products could perhaps result in an
increased incidence in disease. Thereticulum cell sarcoma, a pre-B cell lymphoma,
arises spontaneously in SJL/Jmice (35) . This lymphoma, unlike otherlymphomas,
induces strong proliferative responses by Ly-1 +2,3- T cells (36) . The I-A molecule
of the reticulum cell sarcoma has been reported to differ from the I-A expressed
by normal SJL spleen cells. The major differences appear to be due to more acidic
A« chains (37), and it has been suggested that the RCS I-A molecule is responsible
for the proliferation of the syngeneic T cells and the accompanying tumor growth.
Interestingly, 2PK3 elicits a strong in vitro syngeneic MLR, which, in light of the
novel nature of the determinants formed by the association of Ea and As, may not
be totally unexpected. In man, there have been reports of lymphocyte stimulation
among HLA-identical siblings induced by neoplastic lymphoid cells in an MLR (38,
39). It has been assumed that tumor-specific antigens are responsible for these re-
sponses, however, it is possible that amixed isotype class II molecule or some other
novel form of la maybe the stimulatingmolecule. The observation that certain dis-
ease associations correlate with haplotype rather than with a single locus opens the
possibility that mixed isotypemolecules may play arole in such instances. In addi-
tion, infectious agents may alter class II expression on APC, possibly generating
increased expression of mismatched pairsthat couldthen be recognized by autoreactive
T cell clones. Further examination of the extent of mixed isotype class II molecule
expression, particularly in the case of normal Ia+ cell populations, will provide in-
sight into the physiological significance of these novel class II structures in immune
responses and disease.
Summary
The structures of Ia molecules expressed by two BALB/c B cell lymphoma lines,
A20-1.11 (A20) and 2PK3, were analyzed in an effort to explain the differences in
antigen-presenting capacity displayedby thesecells. Alloreactive T cell hybridomas
specific for I-Ad and antigen-specific, I-Ad-restricted T cells responded well to A20
as the APC. The same alloreactive T cell hybridomas responded weakly or not at638
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all to 2PK3 and the responses of the antigen-specific, I-Ad-restricted T cells were
consistently lower to antigen presented by 2PK3 as compared with A20. T cells re-
stricted to I-Ed responded equally well to either A20 or 2PK3 as APC. Addition-
ally 2PK3, but not A20, stimulated astrong syngeneic mixed lymphocyte response.
Structural analyses of the Ia antigens revealed that I-A and I-E molecules were ex-
pressed by A20, whereas an I-E and a novel I-A-like molecule were expressed by
2PK3 . The novel class II molecule was affinity purified from 2PK3 cells using an
mAb specific for Ad (MK-D6), and this molecule was subsequently shown by an
RIA to react with an Ea-specific mAb (14-4-4S) as well. Chain-specific polyclonal
antisera raised against I-A and I-E a and R chains indicated that the 2PK3 "I-A"
a chain reacted in immunoblot with E,-specific and not Aa-specific antisera, whereas
the (3 chain reacted with Ao- and not ES-specific antisera. Peptide map and partial
amino acid sequence analyses indicated that the "I-A"molecule expressed by 2PK3
represented a mixed isotype structure resulting from the pairingof Ed with Ad. By
immunofluorescence staining analysis, 2PK3 did not react with an mAb specific
for Aa. 2PK3 was capable of limited antigen presentation through the mixed iso-
type molecule to I-Ad-restricted OVA-specific T cell hybridomas, although the re-
sponses induced were low compared with presentation through I-A on A20. Previous
descriptions of the expression ofmixed isotype class II molecules in the mouse have
resulted primarily from DNA-mediated gene transfer experiments. The results
presented indicate that a mixed isotype class 11 molecule can be expressed naturally.
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for their critical review of the manuscript, Michele Pigeon and Dean Allison for technical
assistance, and Kelly Crumrine, Donna Thompson, and Janet Tingle for their patience and
assistance in preparing this manuscript.
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